Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

École Polytechnique de Montréal

$47,825.00

Optical guidance for safe and effective brain tumor biopsy

FY 2016-17

Summary
Brain tumor treatment often involves open-cranium surgery to achieve maximum resection and provide survival benefits.However this is not always the best treatment option and the decision whether or not to proceed with surgery is informed bythe suspected type and grade of the tumor, as well as by the risk/benefit assessment based on the increased likelihood ofpermanent neurological deficits for lesions located in areas controlling, e.g., motor and cognitive functions. When a precisediagnosis is required prior to or in place of surgery, a brain needle biopsy is used to collect tissue specimens. However, thestandard technique often leads to diagnosis errors because of tumor samples being collected in areas not representative ofthe disease. Major complications can also arise due to hemorrhages caused by rupturing of a blood vessel during tissueextraction.The objective of this project is to develop an optical technique that will improve patient safety by limiting the number ofsamples required to achieve an accurate diagnosis and by avoiding the risk of hemorrhage. An integrated optical biopsyneedle will be developed detecting fluorescence, reflectance and inelastic scattering spectra that will be used to quantifytumor-specific biomarkers during the procedure. This information will be provided to the surgeon allowing him/her to decidewhere biopsy specimens should be extracted in order to avoid misdiagnosis. Concurrent with this, diffuse reflectancetechniques will be developed to detect and localize blood vessels by quantifying the distortion of the hemoglobin absorptionsignature due to attenuation by intervening tissue. Not only will the new technology contribute to improving patient safety, butit will also reduce the economical burden on the Canadian health care system by, e.g., reducing the number of repeatprocedures.
Program
Collaborative Health Research Projects
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
462345-2014
Name nom
Leblond, Frederic
Department département
Génie physique
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2014
Award amount
47825
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
3
Nb partie
3
Application title
Optical guidance for safe and effective brain tumor biopsy
Keyword
NSERC
Application summary
Brain tumor treatment often involves open-cranium surgery to achieve maximum resection and provide survival benefits.However this is not always the best treatment option and the decision whether or not to proceed with surgery is informed bythe suspected type and grade of the tumor, as well as by the risk/benefit assessment based on the increased likelihood ofpermanent neurological deficits for lesions located in areas controlling, e.g., motor and cognitive functions. When a precisediagnosis is required prior to or in place of surgery, a brain needle biopsy is used to collect tissue specimens. However, thestandard technique often leads to diagnosis errors because of tumor samples being collected in areas not representative ofthe disease. Major complications can also arise due to hemorrhages caused by rupturing of a blood vessel during tissueextraction.The objective of this project is to develop an optical technique that will improve patient safety by limiting the number ofsamples required to achieve an accurate diagnosis and by avoiding the risk of hemorrhage. An integrated optical biopsyneedle will be developed detecting fluorescence, reflectance and inelastic scattering spectra that will be used to quantifytumor-specific biomarkers during the procedure. This information will be provided to the surgeon allowing him/her to decidewhere biopsy specimens should be extracted in order to avoid misdiagnosis. Concurrent with this, diffuse reflectancetechniques will be developed to detect and localize blood vessels by quantifying the distortion of the hemoglobin absorptionsignature due to attenuation by intervening tissue. Not only will the new technology contribute to improving patient safety, butit will also reduce the economical burden on the Canadian health care system by, e.g., reducing the number of repeatprocedures.